17298481

Source:http://linkedlifedata.com/resource/pubmed/id/17298481

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001645, umls-concept:C0004153, umls-concept:C0035647, umls-concept:C0678951, umls-concept:C1332838, umls-concept:C1704675
pubmed:issue	1
pubmed:dateCreated	2007-6-19
pubmed:abstractText	To investigate whether the angiotensin-converting enzyme (ACE) insertion/deletion (I/D), angiotensinogen M235T or angiotensin II receptor type 1 573C/T polymorphism modify the risk of atherosclerosis associated with beta-blocker or ACE-inhibitor therapy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-10639539, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-10675088, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-11110778, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-11257080, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-11560536, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-12039486, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-12070116, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-12958327, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-1394429, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-14643574, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-15687838, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-15967849, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-1833235, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-1917239, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-1976655, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-7593643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-7664416, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-7854377, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-8075646, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-8686689, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-8728297, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-8952600, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-8973232, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-9040449, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-9315528, http://linkedlifedata.com/resource/pubmed/commentcorrection/17298481-9426030
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503323
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0306-5251
pubmed:author	pubmed-author:HofmanAA, pubmed-author:KlungelO HOH, pubmed-author:SchellemanHH, pubmed-author:StrickerB H ChBH, pubmed-author:WittemanJ C MJC, pubmed-author:de BoerAA, pubmed-author:van DuijnC MCM
pubmed:issnType	Print
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	57-66
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:17298481-Adrenergic beta-Antagonists, pubmed-meshheading:17298481-Aged, pubmed-meshheading:17298481-Aged, 80 and over, pubmed-meshheading:17298481-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:17298481-Antihypertensive Agents, pubmed-meshheading:17298481-Arteriosclerosis, pubmed-meshheading:17298481-Cohort Studies, pubmed-meshheading:17298481-Female, pubmed-meshheading:17298481-Genotype, pubmed-meshheading:17298481-Humans, pubmed-meshheading:17298481-Hypertension, pubmed-meshheading:17298481-Male, pubmed-meshheading:17298481-Middle Aged, pubmed-meshheading:17298481-Netherlands, pubmed-meshheading:17298481-Polymorphism, Genetic, pubmed-meshheading:17298481-Prospective Studies, pubmed-meshheading:17298481-Risk Factors
pubmed:year	2007
pubmed:articleTitle	Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.
pubmed:affiliation	Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't